Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Knowledge, attitudes and barriers to uptake of Covid-19 vaccine in Uganda, February 2021

Bibliographic Data

ID21880801
AuthorsBob Omoda Amodan (0000-0002-4561-1337, Ministry of Health), Patricia Thiwe Okumu (Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda), John Kamulegeya (Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda), Alex Ndyabakira (0000-0002-8420-462X, Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda), Geoffrey Amanya (Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda), Daniel Jacob Emong (Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda), Aggrey Byaruhanga (Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda), Job Morukileng (Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda), Alex Riolexus Ario (0000-0002-3560-1952, Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda)
Year2025
Volume10
Issue3
Pagese016959
Publication date2025-03-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueBMJ Global Health (JOURNAL)
Journal identifiersISSN: 2059-7908 • E-ISSN: 2059-7908
PublisherBMJ (PUBLISHER • GB)
DOI10.1136/bmjgh-2024-016959
PMID40139799
OpenAlexW4408882089
LanguageEN
Citations received1
References cited45

INTRODUCTION: Uganda planned to start its COVID-19 vaccination campaign in March 2021, prioritising healthcare workers, security personnel, elderly and people with comorbidities. However, the willingness to receive the vaccine and potential barriers and hindrances were unknown. To understand the barriers to uptake of the COVID-19 vaccine prior to its rollout, we explored the communities' knowledge, attitudes and barriers. METHODS: We conducted a mixed-methods cross-sectional study in Kampala and Ankole subregions in February 2021. For the household survey, we used three-stage sampling to select three districts in each subregion and, thereafter, 12 villages per district. One adult in each household was interviewed. Additionally, we conducted focus group discussions and key informant interviews to explore knowledge, attitudes and barriers to COVID-19 vaccination. Modified Poisson regression was used to identify factors associated with willingness to receive to COVID-19 vaccine RESULTS: Among 1728 respondents, 52% were under 40 years old, and 67% were female. Fifty-nine percent of those who had heard of the vaccine primarly obtained information from radio and television (TV). Despite one-quarter reporting that they had heard that the vaccine could cause death or genetic changes, 85% were willing to receive it. Persons in the Kampala subregion were less willing than those in the Ankole subregion to take the vaccine (76% vs 94%, adjusted prevalence ratio (aPR)=0.85, 95% CI: 0.81 to 0.89). Trust in the effectiveness of non-vaccine COVID-19 preventive measures (aPR=0.89, 95% CI: 0.80 to 0.99), living in urban areas (aPR=0.84, 95% CI: 0.76 to 0.91) and lack of information on vaccine safety (aPR=0.91, 95% CI: 0.83 to 0.93) reduced interest in taking the vaccine. CONCLUSIONS: Vaccine willingness was high despite some misinformation and safety concerns, which more prevalent in Kampala than in the Ankole subregion. While radio and TV were major sources of COVID-19 vaccine information, social media was the biggest propagator of COVID-19 vaccine misinformation. Therefore, providing credible information about vaccine safety could reinforce uptake, especially among urban residents. Additionally, local and national leaders should publicise their acceptance of vaccines and debunk misinformation

Business · Disease · Environmental health · Family medicine · Focus group · Geography · Poisson regression · Population · Vaccination · COVID-19 Impact on Reproduction · Demography · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Immunology · Internal Medicine

  • Geospatial analysis of Covid-19 vaccine access in Kenya

    Open Access•Jiashuo Sun, Yanjia Cao et al.•Journal of Global Health•2026

  • Covid-19 Vaccine Hesitancy Worldwide

    Open Access•Malik Sallam•Vaccines•2021

  • Covid-19 vaccine hesitancy in the UK

    Open Access•Daniel Freeman, Bao Sheng Loe et al.•Psychological Medicine•2022

  • Measuring vaccine hesitancy

    Open Access•Heidi J Larson, Caitlin Jarrett et al.•Vaccine•2015

  • Covid-19 vaccine hesitancy in Africa

    Open Access•Betty Ackah, Betty B B Ackah et al.•Global Health Research and Policy•2022

  • Vaccine hesitancy

    Open Access•Eve Dubé, Caroline Laberge et al.•Human Vaccines & Immunotherapeutics•2013

  • Challenges in ensuring global access to Covid-19 vaccines

    Open Access•Olivier J Wouters, Kenneth C Shadlen et al.•The Lancet•2021

  • Vaccine hesitancy

    Open Access•Noni E Macdonald•Vaccine•2015

  • Misconceptions on Covid-19 Risk Among Ugandan Men

    Open Access•Keneth Iceland Kasozi, Ewan T Macleod et al.•Frontiers in Public Health•2020

  • Risk factors for incomplete vaccination and missed opportunity for immunization in rural Mozambique

    Open Access•Jagrati V Jani, Caroline De Schacht et al.•BMC Public Health•2008

  • Covid-19 vaccine hesitancy and attitudes in Pakistan

    Open Access•Adnan Ahmad Khan, Mujahid Abdullah et al.•BMC Public Health•2023

  • Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of Covid-19 in 2021

    Open Access•J Yang, Valentina Marziano et al.•Nature Human Behaviour•2021

  • Can a Covid-19 vaccine live up to Americans' expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions

    Open Access•Matthew Motta•Social Science & Medicine•2021

  • How Many Focus Groups Are Enough? Building an Evidence Base for Nonprobability Sample Sizes

    Open Access•Greg Guest, Emily Namey et al.•CAM•2017

Unique citing works1
Citations per year1
Citation span2026 - 2026 (1)
Citation velocitycurrent
Highly citedNo
Citation typesNeutral: 1

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae